Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Aiello

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
ABCA1: regulation, function and relationship to atherosclerosisOmar L Francone, Robert J Aiello
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammationRobert J Aiello, Dominique Brees, Omar L Francone
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2002
Leukotriene B4 receptor antagonism reduces monocytic foam cells in miceRobert J Aiello, Patricia-Ann Bourassa, Saralyn Lindsey, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2005
Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophagesOmar L Francone, Lori Royer, Germaine Boucher, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 31, 2009
Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery diseaseYuval Konstantino, Tu T Nguyen, Robert Wolk, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 24, 2018
Peripartum dietary supplementation of a small-molecule inhibitor of tryptophan hydroxylase 1 compromises infant, but not maternal, boneSamantha R Weaver, Hannah P Fricke, Cynthia Xie, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2002
Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophagesRobert J Aiello, Dominique Brees, Patricia-Ann Bourassa, et al.
Atherosclerosis|October 20, 2009
CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(-/-) miceRobert J Aiello, Bret D Perry, Patricia-Ann Bourassa, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 9, 2016
Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J Aiello, Patricia-Ann Bourassa, Qing Zhang, et al.
Plos One|May 27, 2014
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic ratsDerek M Erion, Amanda Lapworth, Paul A Amor, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
ABCA1: regulation, function and relationship to atherosclerosisOmar L Francone, Robert J Aiello
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammationRobert J Aiello, Dominique Brees, Omar L Francone
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2002
Leukotriene B4 receptor antagonism reduces monocytic foam cells in miceRobert J Aiello, Patricia-Ann Bourassa, Saralyn Lindsey, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2005
Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophagesOmar L Francone, Lori Royer, Germaine Boucher, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 31, 2009
Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery diseaseYuval Konstantino, Tu T Nguyen, Robert Wolk, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 24, 2018
Peripartum dietary supplementation of a small-molecule inhibitor of tryptophan hydroxylase 1 compromises infant, but not maternal, boneSamantha R Weaver, Hannah P Fricke, Cynthia Xie, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 16, 2002
Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophagesRobert J Aiello, Dominique Brees, Patricia-Ann Bourassa, et al.
Atherosclerosis|October 20, 2009
CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE(-/-) miceRobert J Aiello, Bret D Perry, Patricia-Ann Bourassa, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 9, 2016
Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary HypertensionRobert J Aiello, Patricia-Ann Bourassa, Qing Zhang, et al.
Plos One|May 27, 2014
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic ratsDerek M Erion, Amanda Lapworth, Paul A Amor, et al.
Pageof 1